How Small TAM + Regulatory Constraints Disqualify Expansion Deals
- Cormac Repman
- 2h
- 2 min read
I spent the last few years chasing deals in small, regulated markets. The pattern is always the same: you get excited about a prospect, you close the initial account, and then you hit a wall. The expansion ceiling is baked in from the start.
Last week, my team flagged a potential deal that crystallized this lesson perfectly. The prospect operates in a niche market with roughly 100 addressable accounts total. State-specific licensing rules govern who can use the product. Compliance requirements vary by jurisdiction. The TAM is real, but it's tiny and compartmentalized. That's when I realized: I almost would have pursued this anyway.
Here's what I've learned: deals with small addressable markets and regulatory constraints become objection magnets in your pipeline. You spend months navigating compliance conversations, building legal documentation, and educating the prospect on restrictions they didn't know existed. Then you close the first account at 60% of your target deal size because they're nervous about expansion. And the expansion never happens at scale. You can't grow beyond the regulatory boundaries. You can't address new markets because each one comes with its own licensing rules.
The math is brutal. If your TAM is 100 accounts and compliance complexity means only 30% are genuinely addressable in year one, you're working a 30-account market. If your average deal size is 40% smaller because prospects are risk-averse about rolling out a new vendor, you've cut your revenue potential in half. That's assuming perfect execution.
What's worse is the invisible tax on your pipeline. These deals require specialized legal review, custom compliance documentation, extended sales cycles. You're moving slower on a smaller opportunity. Meanwhile, deals in less-regulated markets with larger TAM are sitting in your pipeline, ready to move, ready to expand.
The lesson isn't that you should never pursue regulated niche markets. The lesson is that you need to screen for TAM and compliance complexity early, before you invest serious pipeline time.
We added two hard questions to our qualification framework: What's your total addressable market, and what regulatory constraints govern growth? We're looking for TAM above 500 accounts and regulatory complexity that's manageable within a single region. Below that threshold, the deal becomes a one-off, not a scalable expansion opportunity.
This changes your pipeline behavior. You spend less time educating prospects on their own regulatory environment. You focus on deals where expansion is genuinely possible. Your average deal size stays closer to plan because you're not negotiating down to account for expansion risk.
The team that brought this deal to me did exactly right. They saw the small TAM, flagged the regulatory complexity, and escalated for review rather than pushing it through the pipeline. That's the screening behavior that protects your time.
Your pipeline is your most finite resource. The deals you choose to pursue are the deals you're choosing not to pursue. When you screen early for TAM and regulatory complexity, you're protecting your time for opportunities that scale.
Comments